Holen Sie sich die Stockscreener-App
1.60
4.45%
-0.0745
Handel nachbörslich:
1.60
Schlusskurs vom Vortag:
$1.6745
Offen:
$1.67
24-Stunden-Volumen:
48,610
Relative Volume:
1.55
Marktkapitalisierung:
$18.71M
Einnahmen:
$3.37M
Nettoeinkommen (Verlust:
$-57.28M
KGV:
-0.1488
EPS:
-10.7522
Netto-Cashflow:
$-51.83M
1W Leistung:
+21.21%
1M Leistung:
+26.98%
6M Leistung:
+11.89%
1J Leistung:
-2.44%
1-Tages-Spanne:
$1.56
$1.76
1-Wochen-Bereich:
$1.35
$1.96
52-Wochen-Spanne:
$0.898
$1.96
Synlogic Inc Stock (SYBX) Company Profile
Firmenname
Synlogic Inc
Sektor
Branche
Telefon
617-659-2802
Adresse
PO BOX 30, WINCHESTER, MA
Vergleichen Sie SYBX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYBX
Synlogic Inc
|
1.60 | 15.44M | 3.37M | -57.28M | -51.83M | -10.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Synlogic Inc Stock (SYBX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-11-24 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2019-08-21 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-30 | Eingeleitet | Jefferies | Buy |
| 2018-12-13 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-03-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-01-29 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Synlogic Inc Aktie (SYBX) Neueste Nachrichten
Is Synlogic Inc. a good long term investmentFree Trading Psychology Coaching - jammulinksnews.com
What analysts say about Synlogic Inc. stockHigh-yield market plays - jammulinksnews.com
What drives Synlogic Inc. stock priceSuperior profit margins - jammulinksnews.com
Synlogic Inc. Stock Analysis and ForecastFastest return on investment - jammulinksnews.com
Why Synlogic Inc. stock attracts strong analyst attentionRisk Managed Trading Strategy - Newser
What drives ArrowMark Financial Corp. stock priceUnprecedented profits - jammulinksnews.com
What drives Gores Holdings IX Inc. Equity Warrant stock priceUnrivaled growth potential - Jammu Links News
When is the best time to buy Range Capital Acquisition Corp. stockPortfolio Boosting Stock Alerts - Newser
What makes Synlogic Inc. stock price move sharplyEarly Buy Suggestion - beatles.ru
Why Omnicell Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
How Synlogic Inc. stock performs during market volatilityFree Stock Selection - Newser
What makes The Oncology Institute Inc. Equity Warrant stock price move sharply200 Percent Gain Alert - Newser
5 Best Microbiome Companies (July 2025) - Securities.io
Phenylktonuria Pipeline 2025: Therapies, MOA Insights, and Key - openPR.com
Phenylktonuria Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Erytech Pharma SA, Homology Medicines Inc., Synlogic Inc., BioMarin Pharmaceuticals - Barchart.com
Synlogic's executive sells shares worth $2,802 - MSN
Synlogic Inc. Reports Strategic Shift and Positive Earnings - TipRanks
Synlogic (NASDAQ:SYBX) Stock Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World
Synlogic (SNDX) to Attend Meeting Hosted by B. Riley in New York - GuruFocus
Synlogic (SYBX) Projected to Post Earnings on Tuesday - Defense World
Gene Circuits Market on the Rise with Advancements in Synthetic Biology | Synlogic, Synthego, Ginkgo Bioworks - openPR.com
Renaissance Technologies LLC Decreases Stake in Synlogic, Inc. (NASDAQ:SYBX) - Defense World
Synlogic’s executive Mary Beth Dooley sells $172 in common stock - Investing.com Australia
Synlogic’s executive Mary Beth Dooley sells $172 in common stock By Investing.com - Investing.com UK
SYBX stock touches 52-week low at $1.14 amid market challenges - Investing.com India
The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors - Business Wire
Finanzdaten der Synlogic Inc-Aktie (SYBX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):